Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis

Lataukset:

Montalban, Xavier

Hauser, Stephen L.

Kappos, Ludwig

Arnold, Douglas L.

Bar-Or, Amit

Comi, Giancarlo

de Seze, Jérôme

Giovannoni, Gavin

Hartung, Hans-Peter

Hemmer, Bernhard

Lublin, Fred

Rammohan, Kottil W.

Selmaj, Krzysztof

Traboulsee, Anthony

Sauter, Annette

Masterman, Donna

Fontoura, Paulo

Belachew, Shibeshih

Garren, Hideki

Mairon, Nicole

Chin, Peter

Wolinsky, Jerry S.

Elovaara, Irina

Sumelahti, Marja-Liisa

for the ORATORIO Clinical Investigators

2017

New England Journal of Medicine 376 3
209-220
Lääketieteen ja biotieteiden tiedekunta - Faculty of Medicine and Life Sciences

This publication is copyrighted. You may download, display and print it for Your own personal use. Commercial use is prohibited.